Recent preliminary results from a small randomized trial suggest that men dealing with premature ejaculation can enhance their control and prolong intercourse using a smartphone app.

Premature ejaculation (PE) is identified as the most common sexual dysfunction in men; studies estimate that it affects one in three men. While several treatment options exist, such as local anesthetics and selective serotonin reuptake inhibitors (SSRIs), these often require continuous use and can come with side effects. Furthermore, medications must be taken shortly before sexual activity, which undermines spontaneity. “Current treatments do not resolve the issue,” explains Christer Groeben from the University of Heidelberg in Germany.

The app, named Melonga, offers a comprehensive curriculum crafted by psychologists and urologists that incorporates alertness training, pelvic floor muscle exercises, mindfulness techniques, and cognitive-behavioral strategies. Participants learn to identify the “point of no return” before ejaculation, employing techniques like breathing, relaxation, and start-stop methods to manage arousal. The program also promotes open communication with partners and addresses negative thought patterns using cognitive behavioral therapy.

In a trial, eighty men were randomly chosen to either use the app or receive no structured intervention over the first 12 weeks. Among the 66 men who finished the study, those who used the app increased their vaginal ejaculation latency from an average of 61 seconds to 125 seconds, showing noticeable improvements after just four weeks. The control group exhibited minimal changes.

Men who engaged with the app reported benefits such as improved relationship dynamics and enhanced sexual enjoyment due to prolonged activity. Despite the potential causes of premature ejaculation, like prostate or thyroid issues, the study focused on healthy participants to ensure accurate results.

During a presentation at the European Urological Association Congress in London, Groeben announced significant findings.

“Healthcare professionals often favor medications over simpler solutions,” said Giorgio Russo from the University of Catania, Italy, who was not associated with the study. “During a quick appointment, pills seem like the simplest option, but they are not necessarily what patients need. The app acts as a digital doctor, empowering men and their partners to understand premature ejaculation better.”

Russo highlighted that the app, developed by the Netherlands-based health startup Prognois, had a “dramatic” effect, with 22% of participants no longer fulfilling the criteria for premature ejaculation after its usage. “Even a one- to two-minute improvement can yield significant benefits,” he stated.

“Anxiety is a major factor contributing to premature ejaculation,” Russo added. “Exercises such as Kegels can help manage anxiety and enhance muscle control.” While various similar apps exist, none have been rigorously tested in controlled environments. One key advantage of a digital solution is privacy. “Many individuals avoid seeking medical assistance due to the stigma associated with waiting in a doctor’s office,” Groeben stated.